Javascript must be enabled to continue!
Late-onset schizophrenia
View through CrossRef
Although schizophrenia with onset in middle or late-life is a relatively uncommon, a considerable proportion of patients do experience the first manifestations of the disease after the age of forty. The current nomenclature utilizes terminology based on age at onset: late-onset schizophrenia (LOS) for illness with onset between ages 40 and 60, and very-late-onset schizophrenia-like psychosis (VLOSLP) for onset after age 60. Recent evidence suggests more similarities than differences in epidemiology, etiology or risk factors and clinical presentation between these clinical entities, although a later onset seems to be associated with better premorbid functioning and female gender. Relatively stable cognitive deficits are observed in patients regardless of age at onset and LOS is generally not associated with a dementia, although VLOSLP are more likely to be associated with neurodegenerative processes. Antipsychotic medication is the mainstay of treatment and some psychosocial interventions may prove beneficial, but there is a lack of clinical trials focused on patients with onset in late-life. Response to treatment and outcomes tend to be better than among those with earlier onset, but special consideration should be given to biological and psychosocial factors related to the older age of patients
Title: Late-onset schizophrenia
Description:
Although schizophrenia with onset in middle or late-life is a relatively uncommon, a considerable proportion of patients do experience the first manifestations of the disease after the age of forty.
The current nomenclature utilizes terminology based on age at onset: late-onset schizophrenia (LOS) for illness with onset between ages 40 and 60, and very-late-onset schizophrenia-like psychosis (VLOSLP) for onset after age 60.
Recent evidence suggests more similarities than differences in epidemiology, etiology or risk factors and clinical presentation between these clinical entities, although a later onset seems to be associated with better premorbid functioning and female gender.
Relatively stable cognitive deficits are observed in patients regardless of age at onset and LOS is generally not associated with a dementia, although VLOSLP are more likely to be associated with neurodegenerative processes.
Antipsychotic medication is the mainstay of treatment and some psychosocial interventions may prove beneficial, but there is a lack of clinical trials focused on patients with onset in late-life.
Response to treatment and outcomes tend to be better than among those with earlier onset, but special consideration should be given to biological and psychosocial factors related to the older age of patients.
Related Results
Schizophrenia
Schizophrenia
Schizophrenia is one of the most misunderstood and stigmatized mental illnesses. Discover the truth about this condition, which affects roughly 25 million people worldwide.
...
Emil Kraepelin
Emil Kraepelin
Emil Kraepelin, professor of psychiatry first in Heidelberg then Munich, originated modern psychiatric diagnosis. So it was a fateful error when, in 1899, Kraepelin made catatonia ...
Clozapine for Treatment-Resistant Schizophrenia
Clozapine for Treatment-Resistant Schizophrenia
This chapter provides a summary of a landmark study on the pharmacologic management of treatment-resistant schizophrenia. This clinical trial, conducted by Kane and colleagues, ask...
The ontology and epistemology of symptoms: The case of auditory verbal hallucinations in schizophrenia
The ontology and epistemology of symptoms: The case of auditory verbal hallucinations in schizophrenia
We present a phenomenological account of auditory verbal hallucinations (AVH) in schizophrenia. We examine the mode of articulation of AVH, their spatial and temporal characteristi...
Ecologizing Late Ancient and Byzantine Worlds
Ecologizing Late Ancient and Byzantine Worlds
How can we study the late ancient and Byzantine history from ecological perspectives? How might one grapple with the more-than-human in sources and media created by humans? Explori...
Eugen Bleuler
Eugen Bleuler
Eugen Bleuler, professor of psychiatry in Zurich, renamed Kraepelin’s dementia praecox as “schizophrenia” in 1908. He retained catatonia as a subtype. Bleuler’s dementia praecox wa...
Neurodevelopment and Schizophrenia
Neurodevelopment and Schizophrenia
This book was originally published in 2004 and concerns developmental neurobiology. In the decade preceding publication, developmental neurobiology made important strides towards e...
North American Prodrome Longitudinal Study
North American Prodrome Longitudinal Study
This chapter provides a summary of a landmark study on schizophrenia. The question studied was “In patients identified clinically to be at high risk for psychosis, which variables ...

